Niamh Louise Pellegrini's Net Worth

$6.77 Million

Estimate Recalculated Nov 1, 2024 11:01AM EST

Who is Niamh Louise Pellegrini

Niamh Louise Pellegrini has an estimated net worth of $6.77 Million. This is based on reported shares across multiple companies, which include THORATEC CORP, NEVRO CORP, and Acutus Medical, Inc..

SEC CIK

Niamh Louise Pellegrini's CIK is 0001620611

Past Insider Trading and Trends

2020 was Niamh Louise Pellegrini's most active year for acquiring shares with 6 total transactions. Niamh Louise Pellegrini's most active month to acquire stocks was the month of February. 2020 was Niamh Louise Pellegrini's most active year for disposing of shares, totalling 15 transactions. Niamh Louise Pellegrini's most active month to dispose stocks was the month of September. 2021 saw Niamh Louise Pellegrini paying a total of $146,137.50 for 31,209 shares, this is the most they've acquired in one year. In 2015 Niamh Louise Pellegrini cashed out on 126,555 shares for a total of $6,112,731.57, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

THORATEC CORP

President, North America
Updated Oct 08, 2015
Form 4
-100.00%
-115.33K
$50.61
-$6.11M
Oct 08, 2015
Disposition
Oct 08
Form 4
47.46%
13.10K
Mar 16, 2015
40.70K
Grant
Mar 16
Form 4
102.23K
Oct 15, 2014
102.23K
Grant
Oct 13 - Oct 15
Form 3
Oct 15, 2014
Showing 4 results

NEVRO CORP

Chief Commercial Officer
Updated May 31, 2023
Form 4
-1.31%
-1.14K
$26.45
-$30.23K
May 31, 2023
85.97K
Tax
May 28
Form 4
82.13%
39.28K
Mar 09, 2023
87.11K
Grant
Mar 07
Form 4
-3.97%
-1.98K
$33.99
-$67.27K
Mar 06, 2023
47.83K
Tax
Mar 02
Form 4
-8.65%
-4.72K
$31.44
-$148.33K
Mar 02, 2023
49.81K
Tax
Feb 28
Form 4
-7.41%
-4.37K
$47.11
-$205.64K
Aug 08, 2022
54.53K
Tax
Aug 06
Form 4
-3.33%
-2.03K
$71.27
-$144.75K
Mar 04, 2022
58.89K
Tax
Mar 02
Form 4
74.80%
26.07K
Mar 02, 2022
60.92K
Grant
Feb 28
Form 4
-11.13%
-4.37K
$119.73
-$522.74K
Aug 10, 2021
34.85K
Tax
Aug 06
Form 4
-0.71%
-750.00
$106.52
-$62.35K
Mar 12, 2021
104.79K
Sale
ScheduledMar 10
Form 4
29.31%
8.89K
$168.11
-$118.69K
Mar 04, 2021
39.22K
Grant
Mar 02
Form 4
-0.77%
-750.00
$123.75
-$88.20K
Feb 12, 2021
96.65K
Sale
ScheduledFeb 10
Form 4
-0.76%
-750.00
$117.38
-$78.64K
Jan 13, 2021
97.40K
Sale
ScheduledJan 11
Form 4
-0.76%
-750.00
$113.08
-$72.20K
Dec 14, 2020
98.15K
Sale
ScheduledDec 10
Form 4
-0.75%
-750.00
$117.85
-$79.35K
Nov 12, 2020
98.90K
Sale
ScheduledNov 10
Form 4
-5.65%
-1.82K
$165.00
-$299.80K
Oct 26, 2020
30.33K
Sale
ScheduledOct 22
Form 4
-3.02%
-1.00K
$155.00
-$155.00K
Oct 21, 2020
32.15K
Sale
ScheduledOct 19
Form 4
-1.68%
-1.75K
$107.79
-$214.89K
Oct 13, 2020
102.47K
Sale
ScheduledOct 09 - Oct 13
Form 4
-0.71%
-750.00
$102.04
-$55.64K
Sep 14, 2020
104.22K
Sale
ScheduledSep 10
Form 4
-4.74%
-5.23K
$103.24
-$690.93K
Aug 10, 2020
104.97K
Sale
ScheduledAug 06 - Aug 10
Form 4
16.42%
5.45K
Mar 04, 2020
38.62K
Grant
Mar 02
Form 4
104.75K
Jul 17, 2019
104.75K
Grant
Jul 15
Form 3
Jul 17, 2019
Showing 22 results

Acutus Medical, Inc.

Investor
Updated Jun 15, 2023
Form 4
222.72%
28.00K
Jun 15, 2023
40.57K
Grant
Jun 15
Form 4
671.14%
28.00K
Jun 21, 2022
32.17K
Grant
Jun 16
Form 4
19.36K
Aug 12, 2021
19.36K
Grant
Aug 10
Form 3
Aug 12, 2021
Showing 4 results